Neurology/Psychiatry

The specialty of neurology covers the diagnosis and treatment of diseases affecting the central and peripheral nervous systems and functionally connected structures. This includes vascular diseases of the brain and spinal cord, dementia, epilepsy, headache, inflammatory diseases of the nervous system, tumors involving the nervous system, movement disorders, neuromuscular disorders, and painful syndromes in spinal affections (lower back pain). Various metabolic and degenerative disorders also fall within the scope of neurology.
Stroke is the third most common cause of death in the Czech Republic. Currently there are 30 highly specialized stroke in-patient units providing the highest quality of care and quick access to all needed examination. There are around 300 strokes per 100 000 patients per year.
Currently there are around 17 000 patients with multiple sclerosis, 800-1000 new patients are diagnosed every year. Due to several budgetary restrictions there are long waiting lists for treatment and possibility to take part in clinical trials is welcomed.
According to Czech Alzheimer Society there is around 125 000 patients with dementia in Czech Republic.
Out-patient facilities of psychiatry performed 2 666 thousand examinations of 495 383 patients in 2010. The most frequent problems were neurotic (38 %) and affective (over 19 %) disorders.

A high rate of unplanned re-admissions is an indicator of the quality of several dimensions of the mental health system. Although there is missing the mental health care system in the Czech Republic, the Czech republic has very low re-admission rates.

2.13.1. Mental diseases and psychiatric examinations in out-patient care


Mental diseases and psychiatric examinations in out-patient care
Source: Czech Health Statistics Yearbook, 2011, Institute of Health Information and Statistics of the Czech Republic

 

ISO Across Alliance
Czech biotech company Sotio started pIII trial for prostate cancer with their innovative imunotherapy product http://goo.gl/JDeRuZ 
LinkedIn
Pharmnet © 2017